Literature DB >> 3025221

Identification of an alternatively spliced site in human plasma fibronectin that mediates cell type-specific adhesion.

M J Humphries, S K Akiyama, A Komoriya, K Olden, K M Yamada.   

Abstract

We have compared the molecular specificities of the adhesive interactions of melanoma and fibroblastic cells with fibronectin. Several striking differences were found in the sensitivity of the two cell types to inhibition by a series of synthetic peptides modeled on the Arg-Gly-Asp-Ser (RGDS) tetrapeptide adhesion signal. Further evidence for differences between the melanoma and fibroblastic cell adhesion systems was obtained by examining adhesion to proteolytic fragments of fibronectin. Fibroblastic BHK cells spread readily on fl3, a 75-kD fragment representing the RGDS-containing, "cell-binding" domain of fibronectin, but B16-F10 melanoma cells could not. The melanoma cells were able to spread instead on f9, a 113-kD fragment derived from the large subunit of fibronectin that contains at least part of the type III connecting segment difference region (or "V" region); f7, a fragment from the small fibronectin subunit that lacks this alternatively spliced polypeptide was inactive. Monoclonal antibody and fl3 inhibition experiments confirmed the inability of the melanoma cells to use the RGDS sequence; neither molecule affected melanoma cell spreading, but both completely abrogated fibroblast adhesion. By systematic analysis of a series of six overlapping synthetic peptides spanning the entire type III connecting segment, a novel attachment site was identified in a peptide near the COOH-terminus of this region. The tetrapeptide sequence Arg-Glu-Asp-Val (REDV), which is somewhat related to RGDS, was present in this peptide in a highly hydrophilic region of the type III connecting segment. REDV appeared to be functionally important, since this synthetic tetrapeptide was inhibitory for melanoma cell adhesion to fibronectin but was inactive for fibroblastic cell adhesion. REDV therefore represents a novel adhesive recognition signal in fibronectin that possesses cell type specificity. These results suggest that, for some cell types, regulation of the adhesion-promoting activity of fibronectin may occur by alternative mRNA splicing.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3025221      PMCID: PMC2114617          DOI: 10.1083/jcb.103.6.2637

Source DB:  PubMed          Journal:  J Cell Biol        ISSN: 0021-9525            Impact factor:   10.539


  55 in total

1.  Selection of successive tumour lines for metastasis.

Authors:  I J Fidler
Journal:  Nat New Biol       Date:  1973-04-04

2.  Inhibition of pulmonary metastasis by intravenous injection of specifically activated macrophages.

Authors:  I J Fidler
Journal:  Cancer Res       Date:  1974-05       Impact factor: 12.701

3.  Cell-type-specific fibronectin subunits generated by alternative splicing.

Authors:  J I Paul; J E Schwarzbauer; J W Tamkun; R O Hynes
Journal:  J Biol Chem       Date:  1986-09-15       Impact factor: 5.157

Review 4.  Molecular biology of fibronectin.

Authors:  R Hynes
Journal:  Annu Rev Cell Biol       Date:  1985

5.  Ganglioside inhibition of fibronectin-mediated cell adhesion to collagen.

Authors:  H K Kleinman; G R Martin; P H Fishman
Journal:  Proc Natl Acad Sci U S A       Date:  1979-07       Impact factor: 11.205

6.  Symmetrical Boc-amino acid anhydrides for economical peptide syntheses on a solid phase.

Authors:  T Wieland; C Birr; F Flor
Journal:  Angew Chem Int Ed Engl       Date:  1971-05       Impact factor: 15.336

7.  Localization of the ganglioside-binding site of fibronectin.

Authors:  L K Thompson; P M Horowitz; K L Bentley; D D Thomas; J F Alderete; R J Klebe
Journal:  J Biol Chem       Date:  1986-04-15       Impact factor: 5.157

8.  A synthetic peptide from fibronectin inhibits experimental metastasis of murine melanoma cells.

Authors:  M J Humphries; K Olden; K M Yamada
Journal:  Science       Date:  1986-07-25       Impact factor: 47.728

9.  Fibrillar organization of fibronectin is expressed coordinately with cell surface gangliosides in a variant murine fibroblast.

Authors:  S Spiegel; K M Yamada; B E Hom; J Moss; P H Fishman
Journal:  J Cell Biol       Date:  1986-05       Impact factor: 10.539

10.  Adhesion and cytoskeletal organisation of fibroblasts in response to fibronectin fragments.

Authors:  A Woods; J R Couchman; S Johansson; M Höök
Journal:  EMBO J       Date:  1986-04       Impact factor: 11.598

View more
  88 in total

Review 1.  Tissue engineering in the vascular graft.

Authors:  S P Massia; J A Hubbell
Journal:  Cytotechnology       Date:  1992       Impact factor: 2.058

2.  Click Grafting of Alkyne-containing Vinyl Polymers onto Biosynthesized Extracellular Matrix Protein Containing Azide Functionality and Adhesion Control of Human Umbilical Vein Endothelial Cells.

Authors:  Tomoki Yamada; Akinori Takasu
Journal:  RSC Adv       Date:  2015-01-01       Impact factor: 3.361

3.  Alternative splicing of endothelial cell fibronectin mRNA in the IIICS region. Functional significance.

Authors:  O Kocher; S P Kennedy; J A Madri
Journal:  Am J Pathol       Date:  1990-12       Impact factor: 4.307

4.  Distinct mechanism of human neuroblastoma cell adhesion to fibronectin.

Authors:  T Yoshihara; S Ikushima; Y Shimizu; N Esumi; S Todo; M J Humphries; S Imashuku
Journal:  Clin Exp Metastasis       Date:  1991 Jul-Aug       Impact factor: 5.150

Review 5.  Erythroblastic islands: niches for erythropoiesis.

Authors:  Joel Anne Chasis; Narla Mohandas
Journal:  Blood       Date:  2008-08-01       Impact factor: 22.113

Review 6.  Extracellular matrix molecules and their receptors: functions in neural development.

Authors:  L F Reichardt; K J Tomaselli
Journal:  Annu Rev Neurosci       Date:  1991       Impact factor: 12.449

7.  Structural requirements for biological activity of the ninth and tenth FIII domains of human fibronectin.

Authors:  R P Grant; C Spitzfaden; H Altroff; I D Campbell; H J Mardon
Journal:  J Biol Chem       Date:  1997-03-07       Impact factor: 5.157

8.  A novel tenascin type III repeat is part of a complex of tenascin mRNA alternative splices.

Authors:  P Sriramarao; M A Bourdon
Journal:  Nucleic Acids Res       Date:  1993-01-11       Impact factor: 16.971

9.  Improving functional re-endothelialization of acellular liver scaffold using REDV cell-binding domain.

Authors:  Julie Devalliere; Yibin Chen; Kevin Dooley; Martin L Yarmush; Basak E Uygun
Journal:  Acta Biomater       Date:  2018-07-31       Impact factor: 8.947

10.  Therapeutic ultrasound bypasses canonical syndecan-4 signaling to activate rac1.

Authors:  Claire M Mahoney; Mark R Morgan; Andrew Harrison; Martin J Humphries; Mark D Bass
Journal:  J Biol Chem       Date:  2009-01-15       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.